Laboratory for Cell Biology and Signalling, Division of Molecular Biology, Ruđer Bošković Institute, 10000 Zagreb, Croatia.
Laboratory for Advanced Genomics, Division of Molecular Medicine, Ruđer Bošković Institute, 10000 Zagreb, Croatia.
Viruses. 2022 Mar 24;14(4):672. doi: 10.3390/v14040672.
The low seroprevalent human adenovirus type 26 (HAdV26)-based vaccine vector was the first adenovirus-based vector to receive marketing authorization from European Commission. HAdV26-based vaccine vectors induce durable humoral and cellular immune responses and, as such, represent a highly valuable tool for fighting infectious diseases. Despite well-described immunogenicity in vivo, the basic biology of HAdV26 still needs some refinement. The aim of this study was to determine the pro-inflammatory cytokine profile of epithelial cells infected with HAdV26 and then investigate the underlying molecular mechanism. The expression of studied genes and proteins was assessed by quantitative polymerase chain reaction, western blot, and enzyme-linked immunosorbent assay. Confocal microscopy was used to visualize HAdV26 cell uptake. We found that HAdV26 infection in human epithelial cells triggers the expression of pro-inflammatory cytokines and chemokines, namely IL-6, IL-8, IL-1β, and TNF-α, with the most pronounced difference shown for IL-6. We investigated the underlying molecular mechanism and observed that HAdV26-induced IL-6 gene expression is αvβ3 integrin dependent and NF-κB mediated. Our findings provide new data regarding pro-inflammatory cytokine and chemokine expression in HAdV26-infected epithelial cells, as well as details concerning HAdV26-induced host signaling pathways. Information obtained within this research increases our current knowledge of HAdV26 basic biology and, as such, can contribute to further development of HAdV26-based vaccine vectors.
基于低血清型人腺病毒 26 型(HAdV26)的疫苗载体是首个获得欧盟委员会营销授权的腺病毒载体。基于 HAdV26 的疫苗载体可诱导持久的体液和细胞免疫应答,因此是对抗传染病的极具价值的工具。尽管在体内具有很好描述的免疫原性,但 HAdV26 的基本生物学仍需要一些改进。本研究旨在确定感染 HAdV26 的上皮细胞的促炎细胞因子谱,然后研究其潜在的分子机制。通过定量聚合酶链反应、western blot 和酶联免疫吸附试验评估研究基因和蛋白质的表达。使用共聚焦显微镜观察 HAdV26 细胞摄取。我们发现 HAdV26 感染人上皮细胞会触发促炎细胞因子和趋化因子的表达,即 IL-6、IL-8、IL-1β 和 TNF-α,其中以 IL-6 的差异最为明显。我们研究了潜在的分子机制,观察到 HAdV26 诱导的 IL-6 基因表达依赖于 αvβ3 整联蛋白并受 NF-κB 介导。我们的研究结果提供了有关 HAdV26 感染上皮细胞中促炎细胞因子和趋化因子表达的新数据,以及有关 HAdV26 诱导宿主信号通路的详细信息。在这项研究中获得的信息增加了我们对 HAdV26 基本生物学的现有认识,从而有助于进一步开发基于 HAdV26 的疫苗载体。